These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11953688)

  • 1. Octreotide in patients with active ulcerative colitis treated with high dose corticosteroids (OPUS 1).
    van Bergeijk JD; Wilson JH; Nielsen OH; von Tirpitz C; Karvonen AL; Lygren I; Rädler A; Waldum HL; Mulder CJ; Friis S; Tefera S; Hoogkamer JF;
    Eur J Gastroenterol Hepatol; 2002 Mar; 14(3):243-8. PubMed ID: 11953688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
    Ardizzone S; Maconi G; Russo A; Imbesi V; Colombo E; Bianchi Porro G
    Gut; 2006 Jan; 55(1):47-53. PubMed ID: 15972298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis.
    Feagan BG; Macdonald JK
    Cochrane Database Syst Rev; 2012 Oct; 10():CD000543. PubMed ID: 23076889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-MAdCAM antibody (PF-00547659) for ulcerative colitis (TURANDOT): a phase 2, randomised, double-blind, placebo-controlled trial.
    Vermeire S; Sandborn WJ; Danese S; Hébuterne X; Salzberg BA; Klopocka M; Tarabar D; Vanasek T; Greguš M; Hellstern PA; Kim JS; Sparrow MP; Gorelick KJ; Hinz M; Ahmad A; Pradhan V; Hassan-Zahraee M; Clare R; Cataldi F; Reinisch W
    Lancet; 2017 Jul; 390(10090):135-144. PubMed ID: 28527704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.
    Bosworth BP; Sandborn WJ; Rubin DT; Harper JR
    Inflamm Bowel Dis; 2016 Aug; 22(8):1881-6. PubMed ID: 27416045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basiliximab does not increase efficacy of corticosteroids in patients with steroid-refractory ulcerative colitis.
    Sands BE; Sandborn WJ; Creed TJ; Dayan CM; Dhanda AD; Van Assche GA; Greguš M; Sood A; Choudhuri G; Stempien MJ; Levitt D; Probert CS
    Gastroenterology; 2012 Aug; 143(2):356-64.e1. PubMed ID: 22549092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MMX Multi Matrix System mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials.
    Sandborn WJ; Kamm MA; Lichtenstein GR; Lyne A; Butler T; Joseph RE
    Aliment Pharmacol Ther; 2007 Jul; 26(2):205-15. PubMed ID: 17593066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis.
    Sandborn WJ; Colombel JF; Frankel M; Hommes D; Lowder JN; Mayer L; Plevy S; Stokkers P; Travis S; Van Assche G; Baumgart DC; Targan SR
    Gut; 2010 Nov; 59(11):1485-92. PubMed ID: 20947884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Contemporary views on non-specific ulcerative colitis and conservative methods of its treatment ].
    Bakulin IG; Stanke DA
    Voen Med Zh; 2008 Nov; 329(11):50-4. PubMed ID: 19186525
    [No Abstract]   [Full Text] [Related]  

  • 11. Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.
    Järnerot G; Hertervig E; Friis-Liby I; Blomquist L; Karlén P; Grännö C; Vilien M; Ström M; Danielsson A; Verbaan H; Hellström PM; Magnuson A; Curman B
    Gastroenterology; 2005 Jun; 128(7):1805-11. PubMed ID: 15940615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial.
    Kruis W; Kiudelis G; Rácz I; Gorelov IA; Pokrotnieks J; Horynski M; Batovsky M; Kykal J; Boehm S; Greinwald R; Mueller R;
    Gut; 2009 Feb; 58(2):233-40. PubMed ID: 18832520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MMX mesalazine for the induction of remission of mild-to-moderately active ulcerative colitis: efficacy and tolerability in specific patient subpopulations.
    Lichtenstein GR; Kamm MA; Sandborn WJ; Lyne A; Joseph RE
    Aliment Pharmacol Ther; 2008 Jun; 27(11):1094-102. PubMed ID: 18363894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low dose balsalazide (1.5 g twice daily) and mesalazine (0.5 g three times daily) maintained remission of ulcerative colitis but high dose balsalazide (3.0 g twice daily) was superior in preventing relapses.
    Kruis W; Schreiber S; Theuer D; Brandes JW; Schütz E; Howaldt S; Krakamp B; Hämling J; Mönnikes H; Koop I; Stolte M; Pallant D; Ewald U
    Gut; 2001 Dec; 49(6):783-9. PubMed ID: 11709512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is maintenance therapy always necessary for patients with ulcerative colitis in remission?
    Ardizzone S; Petrillo M; Imbesi V; Cerutti R; Bollani S; Bianchi Porro G
    Aliment Pharmacol Ther; 1999 Mar; 13(3):373-9. PubMed ID: 10102971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis.
    Madsen SM; Schlichting P; Davidsen B; Nielsen OH; Federspiel B; Riis P; Munkholm P
    Am J Gastroenterol; 2001 Jun; 96(6):1807-15. PubMed ID: 11419834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of ulcerative colitis.
    Blonski W; Buchner AM; Lichtenstein GR
    Curr Opin Gastroenterol; 2014 Jan; 30(1):84-96. PubMed ID: 24285003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesalamine once daily is more effective than twice daily in patients with quiescent ulcerative colitis.
    Dignass AU; Bokemeyer B; Adamek H; Mross M; Vinter-Jensen L; Börner N; Silvennoinen J; Tan G; Pool MO; Stijnen T; Dietel P; Klugmann T; Vermeire S; Bhatt A; Veerman H
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):762-9. PubMed ID: 19375519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical treatment of distal active ulcerative colitis with beclomethasone dipropionate or mesalamine: a single-blind randomized controlled trial.
    Gionchetti P; D'Arienzo A; Rizzello F; Manguso F; Maieron R; Lecis PE; Valpiani D; Iaquinto G; Annese V; Balzano A; Varoli G; Campieri M;
    J Clin Gastroenterol; 2005 Apr; 39(4):291-7. PubMed ID: 15758622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study.
    Van Assche G; Ferrante M; Vermeire S; Noman M; Rans K; Van der Biest L; Penninckx F; Wolthuis A; Rutgeerts P; D'Hoore A
    Colorectal Dis; 2012 Apr; 14(4):e181-6. PubMed ID: 21951549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.